Filing Details

Accession Number:
0001209191-17-038222
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-06 18:49:40
Reporting Period:
2017-06-05
Filing Date:
2017-06-06
Accepted Time:
2017-06-06 18:49:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1419600 Flexion Therapeutics Inc FLXN () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1201580 D Samuel Colella C/O Flexion Therapeutics, Inc.
10 Mall Road, Suite 301
Burlington MA 01803
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-05 5,000 $17.01 5,000 No 4 P Indirect By the Colella Family Exempt Marital Deduction Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By the Colella Family Exempt Marital Deduction Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 43,333 Indirect By the Colella Family Trust
Common Stock 25,504 Direct
Common Stock 3,511,670 Indirect See Footnote
Common Stock 20,739 Indirect See Footnote
Common Stock 388,683 Indirect See Footnote
Footnotes
  1. The weighted average purchase price for the transaction reported was $17.0095, and the range of prices were between $16.98 and $17.06. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
  2. The shares are held by the Colella Family Exempt Marital Deduction Trust Dated 9/21/1992 ("Colella Exempt Trust"). The Reporting Person is a trustee and beneficiary of the Colella Exempt Trust.
  3. The shares are held by the Colella Family Trust UTA Dtd. 9/21/92 ("Colella Trust"). The Reporting Person is a trustee and beneficiary of the Colella Trust.
  4. The shares are held by Versant Venture Capital III, L.P. ("VVC III"). The Reporting Person is a managing member of Versant Ventures III, LLC ("VV III"), the sole general partner of VVC III and shares voting and dispositive power over the shares held by VVC III; however, he disclaims beneficial ownership of the shares held by such entity except to the extent of his pecuniary interests therein.
  5. The shares are held by Versant Side Fund III, L.P. ("Side Fund III"). The Reporting Person is a managing member of VV III, the sole general partner of Side Fund III and shares voting and dispositive power over the shares held by Side Fund III; however, he disclaims beneficial ownership of the shares held by such entity except to the extent of his pecuniary interests therein.
  6. The shares are held by Versant Development Fund III, LLC ("Development III"). The Reporting Person is a managing member of VV III, a majority member of Development III and shares voting and dispositive power over the shares held by Development III; however, he disclaims beneficial ownership of the shares held by such entity except to the extent of his pecuniary interests therein.